Characterization of achromobacter species in cystic fibrosis patients: Comparison of blaOXA-114 PCR amplification, multilocus sequence typing, and matrix-assisted laser desorption ionization-time of flight mass spectrometry

Journal of Clinical Microbiology

Volumn 53, Issue 12, 2015, Pages 3894-3896

  Rodrigues, Elenice R A ^a   Ferreira, Alex G ^a   Leão, Robson S ^a   Leite, Cassiana C F ^a   Carvalho Assef, Ana Paula ^c   Albano, Rodolpho M ^b   Marques, Elizabeth A ^a  

^a UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S; BETA LACTAMASE;

ACHROMOBACTER; ACHROMOBACTER DOLENS; ACHROMOBACTER INSUAVIS; ACHROMOBACTER RUHLANDII; ACHROMOBACTER XYLOSOXIDANS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLAOXA 114 GENE; CLINICAL LABORATORY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; GENE SEQUENCE; HUMAN; INFECTION CONTROL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; CLASSIFICATION; COMPLICATION; GENETICS; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIOLOGY; PROCEDURES;

ACHROMOBACTER; BETA-LACTAMASES; CYSTIC FIBROSIS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84947713175     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02197-15     Document Type: Article

References (20)

1. Traglia GM, Almuzara M, Merkier AK, Papalia M, Galanternik L, Radice M, Centrón CVD, Ramiírez MS. (2013). Distribution of allelic variants of the chromosomal gene blaOXA-114-like in Achromobacter xylosoxidans clinical isolates. Curr Microbiol 67: 596-600. http://dx.doi.org/10.1007/s00284-013-0407-5
2. Papalia M, Almuzara M, Cejas D, Traglia G, Ramírez MS, Galanternik L, Vay C, Gutkind G, Radicea M. (2013). OXA-258 from Achromobacter ruhlandii: a species-specific marker. J Clin Microbiol 51: 1602-1605. http://dx.doi.org/10.1128/JCM.03043-12
3. Traglia G, Papalia M, Almuzara M, Gutkind G, Centrón D, Vay C, Radice M, Ramírez MS. 2014 Presence of OXA-type enzymes in Achromobacter insuavis and A. dolens. Curr Microbiol 69: 501-506. http://dx.doi.org/10.1007/s00284-014-0611-y
4. Croxatto A, Prodhom G, Greub G. (2012). Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev 36: 380-407. http://dx.doi.org/10.1111/j.1574-6976.2011.00298.x
5. Wang W, Xi H, Huang M, Wang J, Fan M, Chen Y, Shao H, Li X. (2014). Performance of mass spectrometric identification of bacteria and yeasts routinely isolated in a clinical microbiology laboratory using MALDITOF MS. J Thorac Dis 6: 524-533
6. Homem De Mello De Souza HA, Dalla-Costa LM, Vicenzi FJ, Camargo De Souza D, Riedi CA, Rosário Filho NA, Pilonetto M. (2014). MALDI-TOF: a useful tool for laboratory identification of uncommon glucose non-fermenting Gram-negative bacteria associated with cystic fibrosis. J Med Microbiol 63: 1148-1153. http://dx.doi.org/10.1099/jmm.0.076869-0
7. Fernández-Olmos A, García-Castillo M, Morosini MI, Lamas A, Máiz L, Cantón R. (2012). MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. J Cyst Fibros 11: 59-62. http://dx.doi.org/10.1016/j.jcf.2011.09.001
8. Alby K, Gilligan PH, Millera MB. (2013). Comparison of matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry platforms for the identification of Gram-negative rods from patients with cystic fibrosis. J Clin Microbiol 51: 3852-3854. http://dx.doi.org/10.1128/JCM.01618-13
9. Turton JF, Mustafa N, Shah J, Hampton CV, Pike R, Kenna DT. (2011). Identification of Achromobacter xylosoxidans by detection of the blaOXA-114-like gene intrinsic in this species. Diagn Microbiol Infect Dis 70: 408-411. http://dx.doi.org/10.1016/j.diagmicrobio.2011.02.007
10. Ridderberg W, Wang M, Nørskov-Lauritsen N. (2012). Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans. J Clin Microbiol 50: 2688-2694. http://dx.doi.org/10.1128/JCM.00728-12
11. Spilker T, Vandamme P, Lipuma JJ. (2012). A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species. J Clin Microbiol 50: 3010-3015. http://dx.doi.org/10.1128/JCM.00814-12
12. Hiraishi A. (1992). Direct automated sequencing of 16S rDNA amplified by polymerase chain reaction from bacterial cultures without DNA purification. Lett Appl Microbiol 15: 210-213. http://dx.doi.org/10.1111/j.1472-765X.1992.tb00765.x
13. Pereira RHV, Carvalho-Assef AP, Albano RM, Folescu TW, Jones MCMF, Leão RS, Marques EA. (2011). Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients. J Clin Microbiol 49: 3649-3651. http://dx.doi.org/10.1128/JCM.05283-11
14. De Bel A, Wybo I, Vandoorslaer K, Rosseel P, Lauwers S, Piérard D. (2011). Acceptance criteria for identification results of Gram-negative rods by mass spectrometry. J Med Microbiol 60: 684-686. http://dx.doi.org/10.1099/jmm.0.023184-0
15. Chen JHK, Yam W-C, Ngan AHY, Fung AMY, Woo W-L, Yan M-K, Choi GKY, Ho P-L, Cheng VCC, Yuena K-Y. (2013). Advantages of using matrix-assisted laser desorption ionization-time of flight mass spectrometry as a rapid diagnostic tool for identification of yeasts and mycobacteria in the clinical microbiological laboratory. J Clin Microbiol 51: 3981-3987. http://dx.doi.org/10.1128/JCM.01437-13
16. Gomila M, Prince-Manzano C, Svensson-Stadler L, Busquets A, Erhard M, Martínez DL, Lalucat J, Moore ERB. (2014). Genotypic and phenotypic applications for the differentiation and species-level identification of Achromobacter for clinical diagnoses. PLoS One 9: e114356. http://dx.doi.org/10.1371/journal.pone.0114356
17. Rønne Hansen C, Pressler T, Høiby N, Gormsen M. (2006). Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients: a retrospective case control study. J Cyst Fibros 5: 245-251. http://dx.doi.org/10.1016/j.jcf.2006.04.002
18. Ridderberg W, Bendstrup KEM, Olesen HV, Jensen-Fangel S, Nørskov-Lauritsen N. (2011). Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment. J Cyst Fibros 10: 466-469. http://dx.doi.org/10.1016/j.jcf.2011.07.004
19. Wang M, Ridderberg W, Hansen CR, Høiby N, Jensen-Fangel S, Olesen HV, Skov M, Lemming LE, Pressler T, Johansen HK, Nørskov-Lauritsen N. (2013). Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis. J Cyst Fibros 12: 638-643. http://dx.doi.org/10.1016/j.jcf.2013.04.013
20. Lambiase A, Catania MR, del Pezzo M, Rossano F, Terlizzi V, Sepe A, Raia V. (2011). Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 30: 973-980. http://dx.doi.org/10.1007/s10096-011-1182-5